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Submitted Jan 28, 2014; accepted Mar 12, 2014.DISCUSSIONDr Jeffrey L. Ballard (Orange, Calif). The Stanford group
has nicely presented midterm changes in renal function after
snorkel endovascular aneurysm repair (sn-EVAR). They demon-
strated advantages of sn-EVAR for treatment of complex
aneurysms by increasing juxtarenal aneurysm seal zone from
2 to 20 mm (mean) and decreasing neck diameter from 32 to
25 mm (mean). However, there appears a price to be paid for
sn-EVAR in terms of renal function. No matter which measure
of renal function was used, sn-EVAR was associated with wors-
ening renal function in 41% of their patients. Twenty percent of
patients had a postoperative creatinine level >1.5 and nearly
one-third of patients had creatinine increase of >30%. After
sn-EVAR, renal function was worse in females and in older pa-
tients, particularly those patients over age 70. However, when
compared to other strategies including fenestrated EVAR and
open juxtarenal repair series reported in the literature, these
results are apparently in-line.
The following are my questions for the authors:
1. Describe your speciﬁc sequence of graft deployment, and
might this be related to renal dysfunction?
2. You did not evaluate renal function compared to contrast load.
In your experience, do these cases require more contrast
compared to a routine EVAR case? Would the use of intravas-
cular ultrasound in these cases help to limit IV contrast?
3. Since no independent risk factors were found to predict post
sn-EVAR renal dysfunction, do you do anything differently
in your current cases to protect renal function, or do you
just assume that a decline in renal function is part and parcel
to fenestrated and sn-EVAR?Dr Jason T. Lee. To answer your questions:
1. The speciﬁc sequence of graft deployment is important in
trying to minimize renal artery manipulation and ischemia
time. We recommend careful catheterization of the target
renal arteries from the high brachial approach and insertion
of a 7F sheath into the renal origin, so the snorkel/chimney
stent used (often a balloon-expandable covered stent) can
safely be inserted. When those are in position, the proximal
portion of the main body endograft is deployed, the renal
stents are deployed with balloons inﬂated, an aortic molding
balloon is inﬂated and deﬂated, and ﬁnally the renal snorkels
deﬂated.
2. Multivariate analysis did not ﬁnd that contrast load was a pre-
dictor of renal function decline. Having a standard algorithm
for the procedure has allowed us to be extremely efﬁcient
and judicious in contrast use, and as long as that is kept at a
minimum, the best outcomes can be achieved. Intravascular
ultrasound to mark the renal arteries would save a slight
amount of dye, although we have not routinely used the tech-
nique during our snorkel/chimney procedures.
3. We do believe that some amount of renal function decline is
expected, even with standard EVAR. It was no surprise that
working in the juxtarenal neck provides an even higher risk.
Careful attention to wire and catheter manipulation, changing
to use one half strength dye, and experience of the correct
sequence of wire and catheter shapes/sizes have all improved
our outcomes. Still, further improvement in devices and
continued modiﬁcation of techniques will be necessary to
justify treatment of these complex aneurysms.
